252 related articles for article (PubMed ID: 10082194)
1. Excessive release of [3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists.
Nakai T; Milusheva E; Baranyi M; Uchihashi Y; Satoh T; Vizi ES
Eur J Pharmacol; 1999 Feb; 366(2-3):143-50. PubMed ID: 10082194
[TBL] [Abstract][Full Text] [Related]
2. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
Lockhart B; Iop F; Closier M; Lestage P
Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
[TBL] [Abstract][Full Text] [Related]
3. Implication of ionotropic glutamate receptors in the release of noradrenaline in hippocampal CA1 and CA3 subregions under oxygen and glucose deprivation.
Milusheva EA; Baranyi M
Neurochem Int; 2003 Nov; 43(6):543-50. PubMed ID: 12820982
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of N-methyl-D-aspartate-evoked [3H]noradrenaline release in adult rat spinal cord.
Klarica M; Fage D; Carter C
Eur J Pharmacol; 1996 Jul; 308(2):135-44. PubMed ID: 8840124
[TBL] [Abstract][Full Text] [Related]
5. NMDA and AMPA receptors evoke transmitter release from noradrenergic axon terminals in the rat spinal cord.
Sundström E; Holmberg L; Souverbie F
Neurochem Res; 1998 Dec; 23(12):1501-7. PubMed ID: 9821153
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
7. Participation of AMPA- and NMDA-type excitatory amino acid receptors in the spinal reflex transmission, in rat.
Kocsis P; Tarnawa I; Szombathelyi Z; Farkas S
Brain Res Bull; 2003 Apr; 60(1-2):81-91. PubMed ID: 12725896
[TBL] [Abstract][Full Text] [Related]
8. Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices.
von Kügelgen I; Späth L; Starke K
Br J Pharmacol; 1993 Dec; 110(4):1544-50. PubMed ID: 7508327
[TBL] [Abstract][Full Text] [Related]
9. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
10. Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
Malva JO; Carvalho AP; Carvalho CM
Br J Pharmacol; 1994 Dec; 113(4):1439-47. PubMed ID: 7534187
[TBL] [Abstract][Full Text] [Related]
11. Glucose deprivation increases basal and electrically evoked transmitter release from rat striatal slices. Role of NMDA and adenosine A1 receptors.
Jin S; Fredholm BB
Eur J Pharmacol; 1997 Dec; 340(2-3):169-75. PubMed ID: 9537811
[TBL] [Abstract][Full Text] [Related]
12. Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury.
Li S; Tator CH
Neurol Res; 2000 Mar; 22(2):171-80. PubMed ID: 10763505
[TBL] [Abstract][Full Text] [Related]
13. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
Tzschentke TM; Schmidt WJ
Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
[TBL] [Abstract][Full Text] [Related]
14. Effects of MK-801 and CNQX, glutamate receptor antagonists, on bladder activity in neonatal rats.
Sugaya K; de Groat WC
Brain Res; 1994 Mar; 640(1-2):1-10. PubMed ID: 7911723
[TBL] [Abstract][Full Text] [Related]
15. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
Bleakman D; Ballyk BA; Schoepp DD; Palmer AJ; Bath CP; Sharpe EF; Woolley ML; Bufton HR; Kamboj RK; Tarnawa I; Lodge D
Neuropharmacology; 1996; 35(12):1689-702. PubMed ID: 9076748
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release.
Zelena D; Makara GB; Jezova D
Neuroendocrinology; 1999 May; 69(5):316-23. PubMed ID: 10343172
[TBL] [Abstract][Full Text] [Related]
17. Zn2+ inhibition of [3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate.
Kovács KJ; Larson AA
Eur J Pharmacol; 1997 Apr; 324(1):117-23. PubMed ID: 9137921
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of N-methyl-D-aspartate (NMDA)- and L-glutamate-induced noradrenaline and acetylcholine release in the rat brain by ethanol.
Göthert M; Fink K
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):516-21. PubMed ID: 2575708
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: receptor location, characterization and desensitization.
Fink K; Göthert M; Molderings G; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):514-21. PubMed ID: 2570360
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective interaction effects of NMDA and AMPA receptor antagonists in an in vitro model of cerebral ischemia.
Arias RL; Tasse JR; Bowlby MR
Brain Res; 1999 Jan; 816(2):299-308. PubMed ID: 9878799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
